Heparin-Coated Stent
Source: Cordis Corporation
The Bx VELOCITY Coronary Stent with Hepacoat is indicated for improving coronary luminal diameter in the treatment of abrupt or threatened vessel closure
The Bx VELOCITY Coronary Stent with Hepacoat is indicated for improving coronary luminal diameter in the treatment of abrupt or threatened vessel closure in patients with failed interventional therapy in lesions (less than or equal to 30 mm in length) with reference diameters in the range of 2.25 mm to 4.00 mm. The proprietary heparin coating on the stent retains its properties for periods lasting several months when implanted into blood vessels. This long-term bioactivity, coupled with stable heparin coating remaining on the surface of the device, differentiates it from other coatings designed to improve the hemocompatibility of blood-contacting devices.
Cordis Corporation, PO Box 025700, Miami, FL 33102-5700. Tel: 800-327-7714; Fax: 305-824-2080.
This website uses cookies to ensure you get the best experience on our website. Learn more